A detailed history of Cwm, LLC transactions in Celcuity Inc. stock. As of the latest transaction made, Cwm, LLC holds 342 shares of CELC stock, worth $23,437. This represents 0.0% of its overall portfolio holdings.

Number of Shares
342
Previous 290 17.93%
Holding current value
$23,437
Previous $4,000 325.0%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 15, 2025

BUY
$12.58 - $62.68 $654 - $3,259
52 Added 17.93%
342 $17,000
Q2 2025

Jul 25, 2025

BUY
$8.21 - $13.35 $1,888 - $3,070
230 Added 383.33%
290 $4,000
Q1 2025

May 01, 2025

BUY
$8.62 - $13.62 $318 - $503
37 Added 160.87%
60 $1,000
Q4 2024

Feb 04, 2025

BUY
$12.0 - $16.35 $72 - $98
6 Added 35.29%
23 $0
Q3 2024

Oct 08, 2024

BUY
$13.98 - $19.15 $83 - $114
6 Added 54.55%
17 $0
Q2 2024

Jul 09, 2024

BUY
$14.1 - $20.78 $112 - $166
8 Added 266.67%
11 $0
Q1 2024

Apr 05, 2024

BUY
$13.74 - $21.6 $41 - $64
3 New
3 $0

Others Institutions Holding CELC

About Celcuity Inc.


  • Ticker CELC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,941,300
  • Market Cap $1.02B
  • Description
  • Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...
More about CELC
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.